Investors Snatch GEVA 28.1% Cheaper Than Its Secondary Stock Offering
March 31, 2014 at 10:03 AM EDT
Looking back to 26 days ago, Synageva BioPharma Corp (GEVA) priced a 2,000,000 share secondary stock offering at $105.75 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..
